Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic Field Induced Quantum Spin Liquid in the Two Coupled Trillium Lattices of K_{2}Ni_{2}(SO_{4})_{3}.
Živković I, Favre V, Salazar Mejia C, Jeschke HO, Magrez A, Dabholkar B, Noculak V, Freitas RS, Jeong M, Hegde NG, Testa L, Babkevich P, Su Y, Manuel P, Luetkens H, Baines C, Baker PJ, Wosnitza J, Zaharko O, Iqbal Y, Reuther J, Rønnow HM. Živković I, et al. Among authors: testa l. Phys Rev Lett. 2021 Oct 8;127(15):157204. doi: 10.1103/PhysRevLett.127.157204. Phys Rev Lett. 2021. PMID: 34677991
Radial Spin Texture of the Weyl Fermions in Chiral Tellurium.
Gatti G, Gosálbez-Martínez D, Tsirkin SS, Fanciulli M, Puppin M, Polishchuk S, Moser S, Testa L, Martino E, Roth S, Bugnon P, Moreschini L, Bostwick A, Jozwiak C, Rotenberg E, Di Santo G, Petaccia L, Vobornik I, Fujii J, Wong J, Jariwala D, Atwater HA, Rønnow HM, Chergui M, Yazyev OV, Grioni M, Crepaldi A. Gatti G, et al. Among authors: testa l. Phys Rev Lett. 2020 Nov 20;125(21):216402. doi: 10.1103/PhysRevLett.125.216402. Phys Rev Lett. 2020. PMID: 33274982
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821-3. Online ahead of print. Lancet. 2024. PMID: 38795719
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation after TAVR in Sievers Type-1 Bicuspid Aortic Valves.
Zito A, Buono A, Scotti A, Kim WK, Fabris T, de Biase C, Bellamoli M, Montarello N, Costa G, Alfadhel M, Koren O, Fezzi S, Bellini B, Massussi M, Bai L, Costa G, Mazzapicchi A, Giacomin E, Gorla R, Hug K, Briguori C, Bettari L, Messina A, Villa E, Boiago M, Romagnoli E, Orbach A, Laterra G, Aurigemma C, De Carlo M, Renker M, Gomez MG, Trani C, Ielasi A, Landes U, Rheude T, Testa L, Santos IA, Mangieri A, Saia F, Favero L, Chen M, Adamo M, Petronio AS, Montorfano M, Makkar RR, Mylotte D, Blackman DJ, Barbanti M, De Backer O, Tchètchè D, Tarantini G, Latib A, Maffeo D, Burzotta F. Zito A, et al. Among authors: testa l. JACC Cardiovasc Interv. 2024 May 7:S1936-8798(24)00740-4. doi: 10.1016/j.jcin.2024.05.002. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 38749449 Free article.
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.
Popolo Rubbio A, Testa L, Pivato CA, Regazzoli D, Piccolo R, Esposito G, Musto C, Scalia L, Pacchioni A, Briguori C, Lucisano L, De Luca L, Conrotto F, Tartaglia F, Latini AC, Stankowski K, Chiarito M, Sardella G, Indolfi C, Bedogni F, Reimers B, Condorelli G, Stefanini GG. Popolo Rubbio A, et al. Among authors: testa l. Cardiovasc Revasc Med. 2024 Apr 16:S1553-8389(24)00174-X. doi: 10.1016/j.carrev.2024.04.022. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38702260
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
Bardia A, Pusztai L, Albain K, Ciruelos EM, Im SA, Hershman D, Kalinsky K, Isaacs C, Loirat D, Testa L, Tokunaga E, Wu J, Dry H, Barlow W, Kozarski R, Maxwell M, Harbeck N, Sharma P. Bardia A, et al. Among authors: testa l. Ther Adv Med Oncol. 2024 Apr 29;16:17588359241248336. doi: 10.1177/17588359241248336. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38686016 Free PMC article.
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Goetz MP, Cicin I, Testa L, Tolaney SM, Huober J, Guarneri V, Johnston SRD, Martin M, Rastogi P, Harbeck N, Shahir A, Wei R, André V, Rugo HS, O'Shaughnessy J. Goetz MP, et al. Among authors: testa l. NPJ Breast Cancer. 2024 Apr 26;10(1):34. doi: 10.1038/s41523-024-00639-1. NPJ Breast Cancer. 2024. PMID: 38671001 Free PMC article.
440 results